An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for ARROWHEAD PHARMACEUTICALS IN
| Ticker | ARWR |
| FIGI | BBG000BRVKH0 |
| CUSIP | 04280A100 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 255 / 3.7% |
| Percentage held by institutional investors | 100.0% |
About
Arrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. The company has sixteen products in its pipeline, in various stages of development. Wikipedia